The Microbiome Times

The Microbes in Women's Health Congress takes place in less than two weeks time! 🌸 Women's health is an area of medicine that has historically been under-researched and under-funded resulting in a lack of treatment and product options for a range of common conditions. However, #microbiome research has shown promise in addressing some of these unmet needs. With the microbiome implicated in everything from menopause to pregnancy outcomes, it presents an exciting avenue for closing the R&D gap and a target for novel product development. Join us on 9-10 April in Amsterdam and hear from some of the world's leading researchers from industry and academia that are leveraging microbiome science to improve women's health outcomes, including: Jacques Ravel, Jo-Ann Passmore, Lillian Dillard, PhD, Smita G., Alexiane Decout, Serena Sanna, Caroline Mitchell, Douglas Kwon, Warren Flood, Annette Säfholm, Ina Schuppe Koistinen, Janneke van de Wijgert, Marcel van Duin, PhD, Johan E.T. van Hylckama Vlieg, Sharon Achilles, José Carlos Clemente Litrán, Eldin Jašarević, Marjolein van den Tweel, Issac Chaudry, Pedro Vieira Baptista, Sarah Lebeer, Alessandra (Sandra) Cervino, Inmaculada Moreno Gimeno, Melissa Herbst-Kralovetz, Alaya Mikalauskas, Robert Burk, Karin Strijbis, Sarah Ahannach, Taous SARAOUI-MAZED, Nontokozo Felicity Yusuff, Dr Siobhain O'Mahony, Craig Cohen, Matthew Volpe Find out more and register here: https://lnkd.in/exQcmrG4

The majority of the gut #microbiota is unculturable using standard laboratory techniques, making it difficult to characterise the phenotype and function of many gut bacteria. Bac3Gel, a Portugal-based biotechnology start-up, has developed novel in vitro mucus models for scientists to study gut microbiota without requiring anaerobic incubation and also help biotic developers de-risk their clinical development - Find out more below: https://lnkd.in/dHAnEpQ4

PepsiCo announced that it has entered into a definitive agreement to acquire poppi, a fast-growing prebiotic soda brand, for $1.95 billion: https://lnkd.in/dpZVdBD3

Thank you to everyone who attended the first edition of The Microbiome Times Partnering Forum! Over 350 people visited and over 1000 one-to-one meetings took place over the course of the two days. We hope that we were able to provide an effective platform to foster collaborations and accelerate microbiome innovation. A special thanks to all the members of our advisory board, our sponsors and exhibitors, our association partners (European Microbiome Innovation for Health & Microbiome Therapeutics Innovation Group) and of course, expert speakers - it would not have been possible without you all 🙏 We will work harder to make the 2nd edition bigger and better! Next up…Our Microbes in Women’s Health Congress, 9-10 April in Amsterdam!

The Atlantia team is back for another day of insightful discussions at the The Microbiome Times Forum in Brussels. Yesterday’s opening talks from industry leaders provided valuable perspectives on the complementary relationship between academia and commercial research, highlighting how both sectors collaborate to drive innovation forward. We’re looking forward to more great conversations today! If you’re attending, stop by our stand to meet Barry Skillington, Chief Commercial Officer, and Darren Keane, Sales Executive to chat about how Atlantia Clinical Trials can support your microbiome research, from early-stage development to clinical validation. #MicrobiomeTimesForum #MicrobiomeResearch #ClinicalTrials #AtlantiaClinicalTrials #Networking

A look back at the Microbiome Times Partnering Forum! We're proud to have taken part in this key event, bringing together the major players in #microbiome research and #innovation. 📢 Thank you to the organizers and speakers for these enriching exchanges, as well as to European Microbiome Innovation for Health for its commitment to federating European microbiome players, an objective we fully share. 💡 At #Biocodex, we believe in the synergy between industry and academic research to accelerate innovation. A conviction carried by our Chief Scientific Officer, Oana BERNARD, during her talk on academic partnerships. The Microbiome Times #Science #EMIH #Collaboration #WePlayCollectively

APC Director Prof Paul Ross speaking about the importance of Academic Industry collaborations at the The Microbiome Times Partnering Forum in Belgium this morning. Some of APC's most important research is a result of Industry Partnerships. #Microbiome #Research #industry #collaboration

And we’re off again! Great first day at The Microbiome Times Forum, listening in real Silent Disco style on our latest data, presented by Arno Bouwens 🦠 Come say hi today or tomorrow! Perseus Biomics Matthias Scheffler #metagenomics

Exciting week here at the Microbiome Times Event, Dome Event Centre, Brussels, And looking forward to contributing to a panel session where we will discuss Microbiome Innovation with Consumers front of mind #hhresearch #microbiometimes

📢 Proud to see our CMO, Gianfranco Pittari, MD PhD, presenting our Positive Phase 3 results for MaaT013 at The Microbiome Times Partnering Forum. MaaT013 is developed to treat acute Graft-versus-Host Disease, and has the potential to be the first-approved microbiome-based drug in Europe. 👏 Thank you to The Microbiome Times, in collaboration with Microbiome Therapeutics Innovation Group and European Microbiome Innovation for Health, for bringing together key players in the microbiome field! #aGvHD #Microbiota #Microbiome #Partnerships #Innovation